Towards the Identification of Novel Circulating Biomarkers Associated with Bone Disease in Multiple Myeloma

Ioannis Ntanasis‐Stathopoulos; Panagiota Nikolaou; Charalampos Filippatos; Panagiotis Bakouros; Manousos Makridakis; Ioannis V. Kostopoulos; Christine‐Ivy Liacos; Maria Gavriatopoulou; Antonia Vlachou; Ourania Tsitsilonis; Meletios A Dimopoulos; Evangelos Terpos

doi:10.1016/s2152-2650(25)03650-x

Related publications

Article2021

A Molecular Signature of Circulating MicroRNA Can Predict Osteolytic Bone Disease in Multiple Myeloma

Αριστέα-Μαρία Παπανώτα, Panagiotis Tsiakanikas, Christos K. Kontos, Panagiotis Malandrakis, Christine‐Ivy Liacos, Ioannis Ntanasis‐Stathopoulos, Nikolaos Kanellias, Maria Gavriatopoulou, Efstathios Kastritis, Margaritis Avgeris, Meletios A Dimopoulos, Andreas Scorilas, Evangelos Terpos

Article2009

Novel Anti-Myeloma Agents and Bone Metabolism: Implications in the Management of Myeloma Bone Disease

Evangelos Terpos, Dimitrios Christoulas, Efstathios Kastritis, Magdalini Migkou, Maria Gavriatopoulou, Meletios A Dimopoulos

Article2019

Emerging Insights Into the Role of the Hippo Pathway in Multiple Myeloma and Associated Bone Disease

Anastasios Kyriazoglou, Ioannis Ntanasis‐Stathopoulos, Evangelos Terpos, Despina Fotiou, Efstathios Kastritis, Meletios A Dimopoulos, Maria Gavriatopoulou

Article2011

Circulating Periostin Is Elevated in Patients with Multiple Myeloma and Correlates with Advanced Disease Features and High Bone Resorption,

Evangelos Terpos, Dimitrios Christoulas, Μαρία Γκοτζαμανίδου, Evangelos Eleutherakis‐Papaiakovou, Αθανάσιος Παπαθεοδώρου, Anastasia Pouli, Efstathios Kastritis, Meletios A Dimopoulos

Article2007

The effect of novel anti-myeloma agents on bone metabolism of patients with multiple myeloma

Evangelos Terpos, Meletios A Dimopoulos, Orhan Sezer